Avoid common mistakes on your manuscript.
To the Editor: We thank Rujittika Mngmunpuntipantip and Viroj Wiwanitkit for sharing ideas related to our study on coagulation abnormalities due to COVID-19 in beta-thalassemia children, an issue of current public health importance [1]. In our study, the thalassemia patients had no other congenital hematological disorder comorbidities, especially sickle cell anemia or G-6-PD deficiency [2]. We have screened all of our patients for G-6-PD deficiency possibilities in the initial diagnosis. Pathological problem such vaso-occlusive crises (VOC) might be promoted in individual with both thalassemia and sickle cell disease, especially in alpha-thalassemia population [3]. However, there was no adequate evidence about the occurrence of VOC in beta-thalassemia alone, without sickle cell disease [4]. Abnormal coagulation disorder might also be related to liver-function impairment due to complication of thalassemia itself or as adverse effect of iron chelation use [5, 6]. Based on previous regular laboratory examination, all of included patients in the study had normal liver function without history of hepatitis. After getting infected with COVID-19, 2 of the 4 patients with thalassemia had slight increase in aspartate transaminase enzyme, but not more than 2 times the upper limit. We agree with the authors regarding the importance of excluding other possible confounding pathology that might result in abnormal coagulation profile, especially in SARS-Cov-2 infection associated with transfusion-dependent-thalassemia.
References
Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia: Correspondence. Indian J Pediatr. 2021. https://doi.org/10.1007/s12098-021-03811-8.
Marhaeni W, Wijaya B. Khairiyadi, Munawaroh, Hendriyono. Coagulation abnormalities due to COVID-19 in a child with thalassemia. Indian J Pediatr. 2021;88:396–7.
Renoux C, Connes P, Nader E, et al. Alpha-thalassaemia promotes frequent vaso-occlusive crises in children with sickle cell anaemia through haemorheological changes. Pediatr Blood Cancer. 2017;64. https://doi.org/10.1002/pbc.26455.
Vilela TD, Braga AP, Loggetto SR. Hemoglobinopathy and paediatrics in the time of COVID-19. Hematol Transfus Cell Ther. 2021;43:87–100.
Abosdera MM, Almasry AE, Abdel-Moneim ES. Coagulation defects in thalassemic patients. Pediatr Neonatol. 2017;58:421–4.
Angchaisuksiri P, Atichartakarn V, Aryurachai K, et al. Hemostatic and thrombotic markers in patients with hemoglobin E/B-thalassemia disease. Am J Hematol. 2007;82:1001–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Marhaeni, W., Wijaya, A.B. Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia: Authors’ Reply. Indian J Pediatr 88, 737 (2021). https://doi.org/10.1007/s12098-021-03816-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-021-03816-3